Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
193
datasets available to search
ShareScore release 0.9.0
Dataset results
193 results for “CD20”
Tazemetostat in Combination With Zanubrutinib and Anti-CD20 Monoclonal Antibody in Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT06824701. IPD Sharing: NO. Countries: 1. Publications: 0.
Entecavir Prophylaxis for Hepatitis B Reactivation for CD20 Positive B-cell Lymphoma Patients With Resolved Hepatitis B (Negative Hepatitis B Surface Antigen, Positive Hepatitis B Core Antibody)
ClinicalTrials.gov study NCT05453435. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study Comparing SIBP-02 and Rituximab Combination With CHOP in Previously Untreated Subjects With CD20+ DLBCL
ClinicalTrials.gov study NCT04361279. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Rituximab Plus MG4101 Indolent CD20-positive Non-Hodgkin Lymphoma (NHL)
ClinicalTrials.gov study NCT03578198. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Find a Suitable Dose of ASP2802 in People With CD20-positive B-cell Lymphomas
ClinicalTrials.gov study NCT06248086. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ICP-248 as Monotherapy or in Combination With Anti-CD20 Monoclonal Antibody in Mature B-cell Malignancies
ClinicalTrials.gov study NCT06351527. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Trial of Anti-CD19 and Anti-CD20 Bicistronic Chimeric Antigen Receptor T Cells for Treating B-Cell Malignancies
ClinicalTrials.gov study NCT05797233. IPD Sharing: YES. Countries: 1. Publications: 0.
Rituximab in Combination With Outpatient Therapy for CD20+ Lymphoma
ClinicalTrials.gov study NCT00280878. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of MIL62 in Treatment of CD20 Positive B-cell Lymphomas
ClinicalTrials.gov study NCT04103905. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of TQB2303 in Patients With CD20-Positive Diffuse Large B-cell Lymphoma (DLBCL)
ClinicalTrials.gov study NCT03777085. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety of Autologous Humanized Anti-CD19 and Anti-CD20 Dual Specific CAR-T Cells in Adult Patients With Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT04215016. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I/II Study of TRS005 in Combination With Cyclophosphamide, Doxorubicin, and Prednisone（T-CHP） in Previously Untreated Patients With CD20-positive DLBCL
ClinicalTrials.gov study NCT07035379. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open and Dose-escalation Early Clinical Study of CD19 and CD20 CAR-T Cell Therapy for Relapsed or Refractory Aggressive B-cell Lymphoma
ClinicalTrials.gov study NCT07344818. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Rituximab Plus Chemotherapy for CD20+ Adult Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT01358253. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Dose Finding and Safety Study of CC-220, Alone and in Combination With an Anti-CD20 Monoclonal Antibody (mAb) in Subjects With Relapsed or Refractory Lymphomas
ClinicalTrials.gov study NCT04464798. IPD Sharing: YES. Countries: 6. Publications: 0.
Efficacy and Safety Evaluation of Anti-CD20 Monoclonal Antibody Combined with Azathioprine and Corticosteroids in the Treatment of Pemphigus Vulgaris
ClinicalTrials.gov study NCT06654817. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Phase 1/2 Study of the Combination of Pixantrone, Etoposide, Bendamustine and, in CD20 Positive Tumors, Rituximab in Patients With Relapsed Aggressive Non-Hodgkin Lymphomas of B- or T-cell Phenotype -
ClinicalTrials.gov study NCT02678299. IPD Sharing: NO. Countries: 5. Publications: 0.
A Multicenter Real-life Study of Disseminated Borreliosis Cases Occurring in Patients Receiving Anti-CD20 Treatment in France
ClinicalTrials.gov study NCT07343089. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CD20-CD19 Compound CAR (cCAR) T Cells for Patients With Relapsed /Refractory B Cell Malignancies
ClinicalTrials.gov study NCT04156178. IPD Sharing: NO. Countries: 1. Publications: 0.
Specific Anti-HBV Vaccine Response After Vaccination in Patients Requiring Anti-CD20 Monoclonal Antibodies
ClinicalTrials.gov study NCT04519710. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.